Clinical trials: Prolonged Grief Disorder
Prolonged Grief Disorder, Bereavement
Oxytocin and Approach-avoid in Grief
This is a completed project which was initiated prior to January 18,2017 Background: Theoretical models of complicated grief (CG) suggest that maladaptive approach (e.g., perseverative proximity-seeking of the deceased) or…
- Trial name
- NCT04505904
- Testing
- Syntocinon
- Where
- United States
- Volunteers
- 44 people
- Sponsor
- University of Arizona
Prolonged Grief Disorder
Naltrexone Treatment for Prolonged Grief Disorder (PGD)
This is a study to see how effective oral naltrexone is as treatment for prolonged grief disorder (PGD). Participants will take their assigned medication for 8 weeks, with monthly visits to assess symptom severity, social…
- Trial name
- PGD (NCT04547985)
- Testing
- Naltrexone HCl 50 MG Oral Tablet
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Weill Medical College of Cornell University
Prolonged Grief Disorder
Treatment of Prolonged Grief Disorder in Combat Veterans
The purpose of this study is to compare the efficacy of an experimental treatment (termed BATE-G) for Prolonged Grief Disorder (PGD) in Veterans compared to the current, VA-approved standard of care treatment.
- Trial name
- PGD (NCT02283333)
- Testing
- BATE-G, Standard Treatment
- Where
- 2 sites in United States
- Volunteers
- 155 people
- Sponsor
- VA Office of Research and Development